Referências

1. Diretriz da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto do Miocárdio sem Supradesnível do Segmento ST. Arq Bras Cardiol 2001; 77(supl II):1-38.

2. Braunwald E, Antman EM, Beasley JW,et al. ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST – segment elevation myocardial infarction – summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of patients with Unstable Angina). J Am Coll Cardiol 2002;40:1366-74.

3. SBC – III Diretriz sobre Tratamento do Infarto Agudo do Miocárdio. Arq Bras Cardiol 2004;83(supl IV): 1-86.

4. Antman EM, Anbe DT, Armstrong PW, et al. Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocaqrdial infarction). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction – executive summary: A report of the American College of Cardiology/American Heart Association. J Am Coll Cardiol 2004;44:671-719.

5. SBC – Diretrizes de Doença Coronariana Crônica – Angina Estável. Arq Bras Cardiol 2004;83(supl II):1-43.

6. Sociedade Brasileira de Cardiologia. Diretrizes de Cirurgia “Revascularização Miocárdica, Valvopatias e Doenças da Aorta”. Arq Bras Cardiol 2004;82(Supl V):1-30.

7. Stenestrand U, Tabrizi F, Lindback J, Englund A, Rosenqvist M, Wallentin L. Comorbidity and myocardial dysfunction are the main explanations for the higher 1-year mortality in acute myocardial infarction with left bundle-branch block. Circulation 2004;110(14):1896-902.

8. Shlipak MG, Go AS, Frederick PD, Malmgren J, Barron HV, Canto JG. Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. J Am Coll Cardiol 2000;36:706-12.

9. Grady TA, Chiu AC, Snader CE, Marwick TH, Thomas JD, Pashkow FJ, et al. Prognostic significance of exercise-induced left bundle-branch block. JAMA 1998;279(2):153-6.

10. Ernst ER, Shub C, Bailey KR, Brown LR, Redfield MM. Radiographic measurements of cardiac size as predictors of outcome in patients with dilated cardiomyopathy. J Card Fail 2001;7(1):13-20.

11. II Diretrizes da Sociedade Brasileira de Cardiologia sobre Teste Ergométrico. Arq Bras Cardiol 2002;78(supl II):1-18.

12. Udelson JE, Dilsizian V, Bonow RO, et al. Nuclear Cardiology. In: Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Heart Disease: A Textbook of Cardiovascular Medicine, 7 th edition. Philadelphia: Elsevier-Science, 2004:287-331.

13. I Diretriz da Sociedade Brasileira de Cardiologia Sobre Cardiologia Nuclear. Arq Bras Cardiol 2002;78((supl III):1-42.

14. Diretriz para Indicações e Utilização da Ecocardiografia na Prática Clínica. Arq Bras Cardiol 2004; 82(supl II):12-34.

15. Carney RM, Blumenthal JA, Freedland KE, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005;165(13):1486-91.

16. Diretriz para Realização de Exames Diagnósticos e Terapêuticos em Hemodinâmica. Arq Bras Cardiol 2004;82(supl I): 1-6.

17. Mauss O, Klingenheben T, Ptaszynski P, Hohnloser SH. Bedside risk stratification after acute myocardial infarction: prospective evaluation of the use of heart rate and left ventricular function. J Electrocardiol 2005;38(2):106-12.

18. IV Diretrizes Brasileiras de Hipertensão Arterial. Arq Bras Cardiol 2004;82(supl IV):1-22.

19. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.

20. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.

21. Vaur L, Gueret P, Lievre M, Chabaud S, Passa P and DIABHYCAR Study Group (type 2 DIABetes, Hypertension, CARdiovascular Events and Ramipril) study. Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria. Diabetes Care 2003;26:855-60.

22. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999;19:1992-7.

23. Anavekar NS, McMurray JJV, Velazquez EJ, Solomon SD, Kober L, Rouleau J-L, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95.

24. Goss LZ, Rosa RM, O’Brien WM, Ayers CR, Wood JE.. Predicting death from renal failure in primary hypertension. Arch Intern Med 1969;124(2):160-4.

25. I Diretriz Latino-Americana para Avaliação e Conduta na Insuficiência Cardíaca Descompensada. Arq Bras Cardiol 2005; 85(Supl III):1-48.

26. Revisão das II Diretrizes da Sociedade Brasileira de Cardiologia para o Diagnóstico e Tratamento da Insuficiência Cardíaca. Arq Bras Cardiol 2002; Vol 79(Supl IV):1-30.

27. Swedberg (Chairperson) K, Cleland J, Dargie H, Drexler H, Follath F, Komajda AM, et al. Chronic Heart Failure (Diagnosis and Treatment of)- Executive Summary and Full Text. Eur Heart J 2005; 26:1115-1140.

28. Maron BJ, McKenna (Chairpersons) WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. Wigle Hypertrophic Cardiomyopathy (Clinical Expert Consensus Document on). Eur Heart J 2003;24(21):1965-91.

29. Diagnosis and Management of Chronic Heart Failure in the Adult: ACC/AHA 2005 Guideline Update Circulation 2005;112: (electronic).

30. Valvular Heart Disease: ACC/AHA Practice Guidelines for the Management of Patients with ST-elevation myocardial infarction. J Am Coll Cardiol 1998; 32: 1486-588.

31. Recommendations on the management of the asymptomatic patient with valvular heart disease Eur Heart J. 2002:23:1253–66.

32. Sociedade Brasileira de Cardiologia. Diretrizes de Cirurgia “Revascularização Miocárdica, Valvopatias e Doenças da Aorta”. Arq Bras Cardiol 2004; 82(Supl V):1-30.

33. Ortbals DW, Avioli LV. Tuberculous pericarditis. Arch Intern Med 1979;139:231-4.

34. Fajardo LF, Stewart JR. Pathogenesis of radiation-induced myocardial fibrosis. Lab Invest 1973; 29:244.

35. The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2004;25:587-610.

36. I Consenso Brasileiro de Doença Pulmonar Obstrutiva Crônica. Jornal de Pneumologia 2000; Vol 26(Supl 1).

37. Romano PM, Peterson S. The management of cor pulmonale. Heart Dis. 2000;2:431-7.

38. Task force of the ESC. Grown-Up Congenital Heart Disease. Eur Heart J 2003; 24(11):1035-84.

39. DeSanctis R, Doroghazi W, Austen RM, Buckley MJ. Aortic dissection. N Engl J Med 1987;317:1060-7.

40. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): New Insights Into An Old Disease. JAMA 2000;283:897–903.

41. Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management, part I: from etiology to diagnostic strategies. Circulation 2003;108:628–35.

42. Nienaber CA, von Kodolitsch Y, Petersen B, Loose R, Helmchen U, Haverich A, et al. Intramural hemorrhage of the thoracic aorta:diagnostic and therapeutic implications. Circulation 1995;92:1465–72.

43. Kaji S, Akasaka T, Horibata Y, Nishigami K, Shono H, Katayama M, et al. Long-term prognosis of patients with type A aortic intramural hematoma. Circulation 2002;106(Suppl I):I-248-I-252.

44. Mehta RH, O’Gara PT, Bossone E, Nienaber CA, Myrmel T, Cooper JV, et al. Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol 2002;40:685-92.

45. Debratra M, Eagle KA. Aortic Dissection – An Update. Curr Prob Cardiol 2005;30:287-325.

46. Besser HW. A hipertensão arterial nas doenças cardiovasculares incapacitantes e “Cardiopatia Grave”. Tese de doutorado. Faculdade de Medicina da UFRJ, 2005: 140 p.